Edition:
India

China Resources Pharmaceutical Group Ltd (3320.HK)

3320.HK on Hong Kong Stock

8.84HKD
19 Jul 2019
Change (% chg)

HK$0.02 (+0.23%)
Prev Close
HK$8.82
Open
HK$8.84
Day's High
HK$8.92
Day's Low
HK$8.65
Volume
2,305,500
Avg. Vol
2,493,441
52-wk High
HK$13.16
52-wk Low
HK$8.50

Latest Key Developments (Source: Significant Developments)

China Resources Pharmaceutical Group Says Unit Acquired Shares In Zhejiang Interest'l Group
Tuesday, 16 Jul 2019 

July 16 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::CHINA RESOURCES PHARMACEUTICAL GROUP- ON 9 JULY UNIT ACQUIRED 6.7 MILLION AND 1.6 MILLION SHARES IN ZHEJIANG INTEREST'L GROUP FOR RMB75.3 MILLION AND RMB18.1 MILLION.  Full Article

China Resources Pharmaceutical's Unit Enters Into Loan Agreement With CR Leasing
Monday, 6 May 2019 

May 6 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UNIT ENTERS INTO LOAN AGREEMENT WITH CR LEASING FOR LOAN IN PRINCIPAL AMOUNT OF HK$3 BILLION.  Full Article

China Resources Pharmaceutical Group Says Fu Yuning Resigned As Chairman Of Board
Thursday, 21 Mar 2019 

March 21 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::FU YUNING HAS RESIGNED AS CHAIRMAN OF BOARD.WANG CHUNCHENG APPOINTED AS CHAIRMAN OF BOARD.  Full Article

China Resources Pharmaceutical Gets Approval For Proposed Subscription In Jiangzhong
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::PROPOSED SUPPLEMENTAL SUBSCRIPTION DEAL, JIANGZHONG GROUP TO INCREASE REGISTERED CAPITAL BY ABOUT RMB129.6 MILLION.UNDER AGREEMENT, CR PHARMACEUTICAL HOLDINGS TO CONDITIONALLY MAKE A CAPITAL CONTRIBUTION OF ABOUT RMB3,099.4 MILLION.RECEIVED APPROVAL OF SASAC ON PROPOSED SUBSCRIPTION OF INCREASED REGISTERED CAPITAL IN JIANGZHONG GROUP.  Full Article

China Resources Pharmaceutical Group Enters Into Sales Framework Agreement 2019 With CR Health
Monday, 31 Dec 2018 

Dec 31 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::ENTERED INTO SALES FRAMEWORK AGREEMENT 2019 WITH CR HEALTH.  Full Article

China Resources Pharmaceutical Group Posts HY Profit Attributable Of HK$2.25 Bln
Friday, 24 Aug 2018 

Aug 24 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::HY PROFIT ATTRIBUTABLE HK$2.25 BILLION VERSUS HK$1.81 BILLION.HY REVENUE HK$93.74 BILLION VERSUS HK$82.74 BILLION.  Full Article

China Resources Sanjiu Medical & Pharmaceutical to pay FY 2017 annual div on June 21
Tuesday, 12 Jun 2018 

June 12(Reuters) - China Resources Sanjiu Medical & Pharmaceutical Co Ltd <000999.SZ> ::Says it plans to pay FY 2017 dividend to shareholders of record on June 20.The company's shares will be traded ex-right and ex-dividend on June 21 and the dividend will be paid on June 21.  Full Article

China Resources Pharmaceutical Group Updates On Buying Controlling Stake In Jiangzhong Group
Monday, 4 Jun 2018 

June 4 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UPDATES ON RESTRUCTURE WHEREBY CO WILL ACQUIRE CONTROLLING STAKE IN JIANGZHONG GROUP.OFFER PRICE OF FOR GENERAL OFFER FOR JIANGZHONG PHARMACEUTICAL CO SHALL BE RMB25.03 PER SHARE.TOTAL MAXIMUM CAPITAL AMOUNT NEEDED FOR OFFER IS RMB4.28 BILLION.NUMBER OF SHARES SUBJECT TO OFFER IS 170.9 MILLION LISTED TRADABLE SHARES OF JIANGZHONG PHARMACEUTICAL.COMPLETION OF PROPOSED ACQUISITION WILL TRIGGER OBLIGATION OF GENERAL OFFER FOR SHARES OF JIANGZHONG PHARMA.  Full Article

China Resources Pharmaceutical Group Says In Talks With Jiangxi Government
Wednesday, 16 May 2018 

May 16 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::IN TALKS WITH JIANGXI GOVERNMENT FOR PROPOSED STRATEGIC COOPERATION FRAMEWORK DEAL.CO AND JIANGXI GOVERNMENT CONTEMPLATE TO RESTRUCTURE JIANGZHONG GROUP WHEREBY CO WILL ACQUIRE CONTROLLING STAKE.FRAMEWORK DEAL TO ESTABLISH RELATIONSHIP AIMING TO PROMOTE DEVELOPMENT OF PHARMACEUTICAL INDUSTRY IN JIANGXI.  Full Article

China Resources Pharmaceutical Group Says Unit Enters Loan Agreement With CR Leasing
Monday, 7 May 2018 

May 7 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::ENTERED INTO LOAN AGREEMENT WITH CR LEASING IN RESPECT OF LOAN IN AMOUNT OF HK$3 BILLION FOR 1 YEAR.  Full Article